Provider Knowledge of 2013 Cystic Fibrosis Infection Prevention and Control Guidelines for Outpatient Care
Cindy L Williams1, Maria Ansar2, Juyan J Zhou3
1Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Background:
Chronic lung infections are a hallmark of cystic fibrosis (CF), and the pathogens involved can be transmitted among people with CF (pwCF). The 2013 update of the CF Foundation (CFF) infection prevention and control (IP&C) recommendations emphasized education and monitoring adherence to IP&C practices. Our study aims to assess staff knowledge in outpatient CF clinics, to assess potential barriers to implementation of the 2013 IP&C recommendations, and to identify practice changes resulting from the COVID-19 pandemic.
Methods:
In this multicenter study, electronic surveys were developed and sent to 10 pediatric and 10 adult CF centers between May 2022 and November 2022. Local CF center directors distributed the survey to their outpatient clinical care teams, and responses were anonymous.
Results:
The 174 respondents represented seven different healthcare professions, including respondents from all study sites. Most (72.4%, 126/174) were aware of written CF IP&C policies, but only 50.8% (64/126) knew if the policy specified cleaning roles. Knowledge of the recommended disinfection frequency for specific patient care equipment and high touch surfaces varied strongly by profession (lowest for physicians, highest for certified nursing assistants/medical assistants). Most (77.1%, 215/279) of the responses indicated adherence to recommendations for performing spirometry, with 25.9% (33/127) of respondents reporting no changes in practice during the COVID-19 pandemic. Respondents perceived an increased adherence to use of personal protective equipment and hand hygiene by staff and pwCF since the pandemic.
Conclusion:
While overall awareness of IP&C policies has improved since the 2013 updates, knowledge on specifics should be improved.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...


